Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between May and August 2016
|Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use.
Please find below the number of intra-vitreal injections/implants supplied to patients under the care of Ophthalmology in the 4 months between May and August 2016 (i.e. 1st May to 31st August 2016). Please note that the Trust does not record the indication for treatment on the pharmacy dispensing system so the data may, therefore, include patients who have been treated with these drugs for other indications than those listed in the request.
|AFLIBERCEPT 40 mg per ml Intravitreal Injection||655|
|BEVACIZUMAB 1.25 mg in 0.05ml Intravitreal Injection||25|
|DEXAMETHASONE 0.7 mg Intravitreal Implant||47|
|FLUOCINOLONE ACETONIDE 190 micrograms Intravitreal Implant||2|
|RANIBIZUMAB 0.5 mg Injection||372|